| Trial registration number
|
IRCT20210812052156N1 |
Full text link
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/58082
|
First author
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Dr.Shahla Khosravan
|
Contact
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Nahid.khey00@gmail.com
|
Registration date
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2021-10-27
|
Recruitment status
Last imported at : Oct. 20, 2022, 7:18 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Open label
|
Center
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Consent to participate in research
Diabetes
Patients admitted to the ward with definite diagnosis of COVID-19 with PCR
Disease severity of mild to moderate
|
Exclusion criteria
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Lack of interest to cooperate in research
History of allergies to Linagliptin
Taking interactive drugs at simultaneous use with linagliptin, according to FDA definition
Adverse drug reactions occurrence
|
Number of arms
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Gonabad University of Medical Sciences
|
Inclusion age min
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mild/moderate disease at enrollment
|
Severity scale
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2: Mild/moderate disease at enrollment
|
Total sample size
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
70
|
primary outcome
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Peripheral capillary oxygen saturation
Requirement of non-mechanical ventilation
Requirement of mechanical ventilation
Hospitalization duration
Requirement of ICU
Mortality
|
Notes
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : Oct. 27, 2021, 11:26 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 1780, "treatment_name": "Linagliptin", "treatment_type": "Metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|